Net earnings and adjusted earnings of about $1.0 billion Trailing four-quarter average adjusted ROIC of 13% CHICAGO–(BUSINESS WIRE)–ADM (NYSE: ADM) today reported financial results for the quarter ended September 30, 2022. “I’m proud of our team for delivering yet another quarter of strong results by supporting the global food system and providing needed nutrition to … [Read more…]
Grocer continues partnership with the American Red Cross to protect and rebuild communities JACKSONVILLE, Fla.–(BUSINESS WIRE)–Southeastern Grocers Inc. (SEG), parent company and home of Fresco y Más, Harveys Supermarket and Winn-Dixie grocery stores, announces the donation of $500,000 to the American Red Cross to support vital emergency assistance, disaster preparedness and relief programs for communities … [Read more…]
Namodenoson is now in a global pivotal Phase III study for advanced liver cancer PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced today that a poster entitled “Complete Response Induced by Namodenoson, an … [Read more…]
Data presented at the 2022 American College of Gastroenterology (ACG 2022) Annual Scientific Meeting FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #BarretsEsophagus–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data showing that the use of TissueCypher® Barrett’s Esophagus Test results can significantly improve management decisions for Barrett’s esophagus … [Read more…]
This is expected to be the first clinical proton therapy system in Wisconsin LITTLETON, Mass.–(BUSINESS WIRE)–#MEVIONS250i–Mevion Medical Systems is pleased to announce it has entered into a contract with the Froedtert & the Medical College of Wisconsin health network to bring the MEVION S250i Proton Therapy System® to Wisconsin. The system will be installed at … [Read more…]
INDIANAPOLIS–(BUSINESS WIRE)–The Board of Directors of Elevance Health (NYSE: ELV) announced that Deanna Strable will be joining the Board. She will serve on the Audit and Governance Committees. With a career spanning more than three decades at a Fortune 500 global financial services company, Ms. Strable currently serves as the executive vice president and chief … [Read more…]
NEWNAN, Ga.–(BUSINESS WIRE)–#DME–David Bedard, ATP, C.H.A.M.P. has joined ATF Medical as manager of complex rehab technology. ATF Medical supplies all the mobility equipment, rehabilitation and assistive technologies, and adaptive housing solutions that a complex workers’ compensation claim needs. Bedard oversees day-to-day operations and quality assurance for a team of professionals who help workers’ compensation payers … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Infectious Diseases Partnering 2015-2022: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. The Global Infectious Diseases Partnering 2015-2022 report provides comprehensive access to available deals and contract documents for over 2,900 infectious diseases deals. Most of the deals included within the report occur when a licensee obtains a … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Specialty Pharmaceutical Partnering Terms and Agreements 2015-2022” report has been added to ResearchAndMarkets.com’s offering. The Global Specialty Pharmaceutical Partnering Terms and Agreements 2015 to 2022 report provides comprehensive access to available deals and contract documents for over 1,500 Specialty Pharmaceutical deals. This report provides details of the latest Specialty Pharmaceutical agreements announced … [Read more…]
THE HAGUE, The Netherlands–(BUSINESS WIRE)–#AMR–Dutch/Swiss biotech company Micreos announced today it has secured its next funding round of €25 million in growth capital and for clinical development of its endolysin technology platform, set to replace antibiotics in many areas. This technology enables – for the first time – targeted killing of only the unwanted bacteria, … [Read more…]
